Healthcare

● No earnings, partnership, or regulatory news explained the single-day move.

● The raise followed quarterly results from the imaging and diagnostics maker.

● The trial met its endpoints in head and neck cancer patients.

● The move was among the strongest in the healthcare sector that day.

● No confirmed company-specific catalyst could be established for the drop.

● The company raised its full-year forecast alongside the record results.

● The guidance increase was the confirmed driver behind the move.